Joseph Kim, M.D., FACS
Dr. Joseph Kim is a surgical oncologist in Lexington, Kentucky. As Chief of Surgical Oncology at the UK Markey Cancer Center, his area of expertise is the surgical treatment of hepatobiliary, gastric, peritoneal mesothelioma, and pancreatic cancers. He is also a member of Markey’s multidisciplinary evaluation and treatment team.[]
Education and Career
Dr. Kim earned his medical degree at the Loyola University Chicago Stritch School of Medicine and then completed his internship and residency in General Surgery at the University of Cincinnati College of Medicine.
From there, he went on to complete a clinical and research fellowship in Surgical Oncology at the John Wayne Cancer Institute in Santa Monica, California.[1]
Dr. Kim held surgical oncology leadership roles at the City of Hope Hospital in Duarte, California, and at the State University of New York at Stony Brook. He was part of a team that performed the first fully robotic Whipple procedure on Long Island on a patient with stage II pancreatic cancer.
Dr. Kim is currently a surgical oncologist and the Chief of the Division of Surgical Oncology for UK HealthCare. He also holds the faculty rank of Professor of Surgery. He sees patients at the Markey Cancer Center in Lexington and specializes in GI and abdominal cancers.
Dr. Kim is skilled in the use of minimally invasive robotic surgery techniques and has performed more than 100 robotic GI procedures.
He also has more than 15 years of experience in performing the complex procedure known as CRS-HIPEC (cytoreductive surgery and hyperthermic intraperitoneal chemotherapy), which involves removing all of the malignant material that he can see, followed by administering a heated solution of chemotherapy directly into the surgical site.[2]
Publications
Dr. Kim has published extensively on the subject of HIPEC and authored a chapter titled “Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Mucinous Tumors of the Gastrointestinal Tract” in the book Gastrointestinal Cancers: Prevention, Detection and Treatment.
He authored the chapter “Diseases of the Peritoneum and Retroperitoneum” published in ACS Surgery: Principles and Practice, as well as a peer-reviewed article titled “Reduced Morbidity Following Cytoreductive Surgery and Intraperitoneal Hyperthermic Chemoperfusion” published in Annals of Surgical Oncology.[2]
